Atsushi “Andy” Fujimoto, Mitsubishi Tanabe Pharma America president
FDA approves oral formulation of old ALS drug, giving patients new treatment option in sorely needed field
Much of the ALS drug news in recent months has focused on Amylyx Pharmaceuticals and its experimental program reviewed by an FDA advisory committee in …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.